Found: 6
Select item for more details and to access through your institution.
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14572, doi. 10.1038/ncomms14572
- By:
- Publication type:
- Article
A paracrine requirement for hedgehog signalling in cancer.
- Published in:
- Nature, 2008, v. 455, n. 7211, p. 406, doi. 10.1038/nature07275
- By:
- Publication type:
- Article
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.
- Published in:
- NPJ Precision Oncology, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41698-018-0051-4
- By:
- Publication type:
- Article
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19402-8
- By:
- Publication type:
- Article
High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056765
- By:
- Publication type:
- Article
Developing biomarkers to predict benefit from HGF/ MET pathway inhibitors.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 210, doi. 10.1002/path.4268
- By:
- Publication type:
- Article